Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.

  title={Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.},
  author={Tanya V Stewart and Nick Pavlakis and Matt Ward},
  journal={Internal medicine journal},
  volume={40 4},
In this case series we present a variety of different cardiac toxicities with 5-fluorouracil and its pro-drug capecitabine, including myocardial infarction, cardiomyopathy, sinoatrial and atrioventricular node dysfunction, takotsubo cardiomyopathy and QT prolongation with torsade-de pointes ventricular tachycardia. We stress the fact that while vasospasm is a well-recognized side-effect of this class of chemotherapeutic agent, broader cardiotoxicity is commonly seen and an increased awareness… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 28 extracted citations


Publications referenced by this paper.
Showing 1-10 of 17 references

The Authors Journal compilation © 2010 Royal Australasian College of Physicians

  • Stewart
  • 2010

Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

  • SA Jensen, JB Sorensen
  • Cancer Chemother Pharmacol
  • 2006

pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer

  • E Van Cutsem, PM Hoff, JL Blum, M Abt, B. Osterwalder
  • (CRC). Eur J Cancer
  • 2005

Cardiotoxicity of the antiproliferative compound fluorouracil

  • JF Erckenbrecht, D Haussinger, T Frieling
  • Drugs
  • 1999

Similar Papers

Loading similar papers…